S&P 500   4,662.85
DOW   35,911.81
QQQ   380.01
S&P 500   4,662.85
DOW   35,911.81
QQQ   380.01
S&P 500   4,662.85
DOW   35,911.81
QQQ   380.01
S&P 500   4,662.85
DOW   35,911.81
QQQ   380.01
NASDAQ:NPCE

NeuroPace News Headlines

$10.36
-0.44 (-4.07%)
(As of 01/14/2022 12:00 AM ET)
Add
Compare
Today's Range
$10.00
$10.86
50-Day Range
$8.63
$16.95
52-Week Range
$8.29
$27.38
Volume
31,384 shs
Average Volume
71,576 shs
Market Capitalization
$251.85 million
P/E Ratio
N/A
Dividend Yield
N/A
Beta
N/A
Get NeuroPace News Delivered to You Automatically

Sign up to receive the latest news and ratings for NPCE and its competitors with MarketBeat's FREE daily newsletter.

Media Mentions By Week

NeuroPace Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

NPCE
News Sentiment

-0.12

0.31

Average
Medical
News Sentiment

Media Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

NPCE Articles
This Week

3

0

NPCE Articles
Average Week



NeuroPace (NASDAQ:NPCE) News Headlines Today

SourceHeadline
MarketBeat logoNeuroPace, Inc. (NASDAQ:NPCE) Receives Consensus Recommendation of "Buy" from Analysts
americanbankingnews.com - January 14 at 4:52 AM
seekingalpha.com logoNeuroPace forecasts prelim Q4 revenue of $11M
seekingalpha.com - January 11 at 5:25 PM
finance.yahoo.com logoNeuroPace Announces Preliminary Unaudited Fourth Quarter and Full-Year 2021 Revenue
finance.yahoo.com - January 11 at 5:25 PM
MarketBeat logoNeuroPace (NASDAQ:NPCE) Rating Lowered to Underweight at Morgan Stanley
americanbankingnews.com - January 7 at 7:23 PM
finance.yahoo.com logoNeuroPace to Present at 40th Annual J.P. Morgan Healthcare Conference
finance.yahoo.com - December 16 at 8:48 AM
au.finance.yahoo.com logoNeuroPace Receives IDE Approval to Initiate NAUTILUS Pivotal Study of its RNS System for Idiopathic Generalized Epilepsy
au.finance.yahoo.com - November 12 at 10:07 AM
finance.yahoo.com logoNeuroPace, Inc. (NPCE) Q3 2021 Earnings Call Transcript
finance.yahoo.com - November 11 at 1:45 PM
finance.yahoo.com logoNeuroPace Reports Third Quarter 2021 Financial Results
finance.yahoo.com - November 10 at 7:38 PM
benzinga.com logoLooking Into NeuroPace's Return On Capital Employed
benzinga.com - November 10 at 2:37 PM
finance.yahoo.com logoNeuroPace to Report Third Quarter 2021 Financial Results on November 10, 2021
finance.yahoo.com - October 20 at 7:28 PM
finance.yahoo.com logoNeuroPace Announces Addition of Lisa Andrade to the Board
finance.yahoo.com - October 19 at 6:03 PM
finance.yahoo.com logoCalculating The Fair Value Of NeuroPace, Inc. (NASDAQ:NPCE)
finance.yahoo.com - September 20 at 12:40 PM
finance.yahoo.com logoNeuroPace to Participate in Upcoming Conferences
finance.yahoo.com - August 23 at 6:26 PM
finance.yahoo.com logoNeuroPace, Inc. (NPCE) Q2 2021 Earnings Call Transcript
finance.yahoo.com - August 13 at 8:37 AM
finance.yahoo.com logoNeuroPace Reports Second Quarter 2021 Financial Results
finance.yahoo.com - August 12 at 5:35 PM
finance.yahoo.com logoNeuroPace Launches nSight Platform and Partnership with Seizure Tracker™ to Provide Doctors With Personalized Information About Their Patients’ Seizure Burden
finance.yahoo.com - August 4 at 1:01 PM
finance.yahoo.com logoNeuroPace To Report Second Quarter 2021 Financial Results on August 12, 2021
finance.yahoo.com - July 22 at 7:16 PM
finance.yahoo.com logoHave Insiders Been Buying NeuroPace, Inc. (NASDAQ:NPCE) Shares?
finance.yahoo.com - July 22 at 2:16 PM
finance.yahoo.com logoNeuroPace Awarded Five-Year NIH Grant Funding of More than $9M to Study RNS System in Patients with Lennox-Gastaut Syndrome
finance.yahoo.com - June 30 at 9:43 AM
barrons.com logoNeuroPace Inc.
barrons.com - June 9 at 11:53 PM
finance.yahoo.com logoNeuroPace Inc to Host Earnings Call
finance.yahoo.com - June 3 at 9:37 AM
finance.yahoo.com logoNeuroPace Reports First Quarter 2021 Financial Results and Provides 2021 Financial Guidance
finance.yahoo.com - June 3 at 9:37 AM
finance.yahoo.com logoNeuroPace To Report First Quarter 2021 Financial Results on June 3, 2021
finance.yahoo.com - May 20 at 8:33 AM
nasdaq.com logoNeuropace, Inc. Rings The Nasdaq Stock Market Closing Bell
nasdaq.com - April 28 at 1:05 AM
markets.businessinsider.com logoNeuroPace, Inc. Announces Closing of Initial Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional Shares
markets.businessinsider.com - April 26 at 6:34 PM
nasdaq.com logoMonday 4/26 Insider Buying Report: NPCE, ODC
nasdaq.com - April 26 at 1:34 PM
Get NeuroPace News Delivered to You Automatically

Sign up to receive the latest news and ratings for NPCE and its competitors with MarketBeat's FREE daily newsletter.

This page was last updated on 1/16/2022 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.